share_log

HC Wainwright & Co. Reiterates Buy on Atossa Therapeutics, Maintains $4 Price Target

HC Wainwright & Co. Reiterates Buy on Atossa Therapeutics, Maintains $4 Price Target

HC Wainwright & Co.重申買入Atossa Therapeutics,維持4美元的目標股價
Moomoo 24/7 ·  04/16 11:01

HC Wainwright & Co. analyst Emily Bodnar reiterates Atossa Therapeutics (NASDAQ:ATOS) with a Buy and maintains $4 price target.

HC Wainwright & Co. 分析師艾米麗·博德納爾重申Atossa Therapeutics(納斯達克股票代碼:ATOS)的買入並維持4美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論